CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2600
-0.0002 (-0.08%)
Aug 8, 2025, 3:59 PM EDT
Paramount Global Market Cap
CytoDyn has a market cap or net worth of $322.85 million as of August 8, 2025. Its market cap has increased by 118.02% in one year.
Market Cap
322.85M
Enterprise Value
338.28M
Revenue
n/a
Ranking
n/a
PE Ratio
141.58
Stock Price
$0.26
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 322.85M, an increase of 5,730.11%. That is a compound annual growth rate of 22.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 322.85M | 139.79% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | 3.21B | 695.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 625.65M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 366.75M |
| American Oncology Network | 353.52M |
| Alterola Biotech | 296.25M |